On May 3, 2021, Precipio announced that it had successfully launched its COVID-19 rapid antibody test (20 minute) which tests for both IgG & IgM antibodies, on Amazon.com’s business platform. Precipio holds the exclusive rights to distribute this product on Amazon’s platform.

The antibody test, manufactured in the USA by Nirmidas Biotech, of California, was the first US-based test to receive emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for point-of-care.